Inspire Medical Systems, Inc. (INSP)
INSPNYSEMedical/Dental Instruments
$62.00
-2.33 (-3.62%) today
At the close, Nov 10, 4:00 PM ET. After hours $62.31 +0.11%
- Market cap
- $1.80bn
- P/E
- 30.5
- EPS, last 4 quarters
- $2.03
- Dividend yield
- –
- Day range
- $61.88 to $63.94
- 52-week range
- $38.91 to $147.03
- Average volume
- 336.7k
- Previous close
- $64.33
Analysts
13 coveringHold4 buy, 7 hold, 2 sell
Targets a year out average $73.08, +17.9% from here
Earnings
next estimate $0.9100Next report
Dec 2025
+139.1%
Mar 2026
+127.8%
Jun 2026
+163.6%
Sep 2026
+40.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $269.08m | $204.58m | $200.58m | $206.69m |
| Gross profit | $233.01m | $176.91m | $171.46m | $177.86m |
| Operating income | $46.11m | -$1.12m | -$514.0k | -$28.72m |
| Net income | $136.09m | -$11.29m | $314.0k | -$24.39m |
Last four quarters: revenue $880.94m, margin 11.4%, free cash flow $97.89m
News
8 latest- INSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here?Zacks · 4 hours ago
- Inspire Turns Q3 Loss Of $24 Mln With Higher Expenses; Narrows Revenue Guidance For 2026 RTTNews · Nov 3, 2026
- Inspire (INSP) Q3 2026 Earnings Call TranscriptThe Motley Fool · Nov 3, 2026
- Inspire Medical Systems Q3 Earnings Call HighlightsMarketBeat · Nov 2, 2026
- Inspire Medical Systems (INSP) Q3 Earnings and Revenues Beat EstimatesZacks · Nov 2, 2026
- Here's What Key Metrics Tell Us About Inspire (INSP) Q3 EarningsZacks · Nov 2, 2026
- Inspire Medical Systems Q3 26 Earnings Conference Call At 5:00 PM ET RTTNews · Nov 2, 2026
- INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?Zacks · Oct 23, 2026
The company
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NYSE
- Region
- North America
- Website
- inspiresleep.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.